Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes.

Sanda S, Roep BO, von Herrath M.

Clin Immunol. 2008 May;127(2):138-43. doi: 10.1016/j.clim.2007.12.003.

PMID:
18304876
2.

The 'dead in bed syndrome'- a cause of sudden death in Type 1 diabetes mellitus.

Start RD, Barber C, Kaschula RO, Robinson RT.

Histopathology. 2007 Dec;51(6):843-5. No abstract available.

PMID:
17894803
3.

Update on the current status of peptide immunotherapy.

Larché M.

J Allergy Clin Immunol. 2007 Apr;119(4):906-9. Review.

PMID:
17418662
4.

Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Staeva-Vieira T, Peakman M, von Herrath M.

Clin Exp Immunol. 2007 Apr;148(1):17-31. Review. Erratum in: Clin Exp Immunol. 2007 Jul;149(1):203.

5.
6.

Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes.

Alizadeh BZ, Hanifi-Moghaddam P, Eerligh P, van der Slik AR, Kolb H, Kharagjitsingh AV, Pereira Arias AM, Ronkainen M, Knip M, Bonfanti R, Bonifacio E, Devendra D, Wilkin T, Giphart MJ, Koeleman BP, Nolsøe R, Mandrup Poulsen T, Schloot NC, Roep BO; DIABMARKER Study Group..

Clin Exp Immunol. 2006 Sep;145(3):480-4.

7.

Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.

Tarzi M, Klunker S, Texier C, Verhoef A, Stapel SO, Akdis CA, Maillere B, Kay AB, Larché M.

Clin Exp Allergy. 2006 Apr;36(4):465-74.

PMID:
16630151
8.

Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.

Alleva DG, Maki RA, Putnam AL, Robinson JM, Kipnes MS, Dandona P, Marks JB, Simmons DL, Greenbaum CJ, Jimenez RG, Conlon PJ, Gottlieb PA.

Scand J Immunol. 2006 Jan;63(1):59-69.

9.

Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC.

Diabetologia. 2005 Nov;48(11):2221-8.

PMID:
16205882
10.

A comprehensive review of interventions in the NOD mouse and implications for translation.

Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT.

Immunity. 2005 Aug;23(2):115-26. Review.

11.

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes.

Agardh CD, Cilio CM, Lethagen A, Lynch K, Leslie RD, Palmér M, Harris RA, Robertson JA, Lernmark A.

J Diabetes Complications. 2005 Jul-Aug;19(4):238-46.

PMID:
15993359
12.

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L.

N Engl J Med. 2005 Jun 23;352(25):2598-608.

13.

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E.

Diabetes Care. 2005 May;28(5):1068-76.

PMID:
15855569
14.

Peptide-based therapeutic vaccines for allergic and autoimmune diseases.

Larché M, Wraith DC.

Nat Med. 2005 Apr;11(4 Suppl):S69-76. Review.

PMID:
15812493
15.

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity.

Verhoef A, Alexander C, Kay AB, Larché M.

PLoS Med. 2005 Mar;2(3):e78.

16.

Specific antigen vaccination to treat autoimmune disease.

McDevitt H.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14627-30. Review.

17.

Preventing peptide-induced anaphylaxis: addition of C-terminal amino acids to produce a neutral isoelectric point.

Liu E, Moriyama H, Abiru N, Paronen J, Devendra D, Finkelman FD, Eisenbarth GS.

J Allergy Clin Immunol. 2004 Sep;114(3):607-13.

PMID:
15356565
18.

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.

Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M.

J Clin Invest. 2004 Feb;113(3):451-63.

19.

Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.

Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, Bonifacio E, Ziegler AG.

Diabetes. 2004 Feb;53(2):384-92. Erratum in: Diabetes. 2004 Apr;53(4):1175-6.

20.

Role of interleukin-10 in the induction and function of natural and antigen-induced regulatory T cells.

Wraith DC.

J Autoimmun. 2003 Jun;20(4):273-5. Review. No abstract available.

PMID:
12791311
Items per page

Supplemental Content

Support Center